Distributors are increasingly looking to highways instead of railroads for transportation to get around bottlenecks and avoid delays, The Wall Street Journal reported Feb. 21.
Nearly 49,000 courses of Eli Lilly’s bebtelovimab — a monoclonal antibody treatment effective against omicron — have been distributed throughout the U.S. since the FDA issued an emergency use authorization for the drug Feb. 11.
About 73 percent of U.S. physicians aren’t confident in the supply chain’s ability to deliver safe, quality medicines, according to recent survey findings.
The Justice Department and FBI have enacted a new initiative to detect and prosecute collusive exploitation of supply chain disruptions, the department said Feb. 16.